DexCom Inc (DXCM)

DXCM (NASDAQ:Health Services) EQUITY
pos +0.00
Today's Range: 0.00 - 0.00 | DXCM Avg Daily Volume: 816,500
Last Update: 09/29/16 - 4:00 PM EDT
Volume: 0
YTD Performance: 7.20%
Open: $0.00
Previous Close: $87.80
52 Week Range: $47.92 - $96.38
Oustanding Shares: 83,883,617
Market Cap: 7,527,715,790
6-Month Chart
TheStreet Ratings Grade for DXCM
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 8 8 8 9
Moderate Buy 2 2 2 2
Hold 4 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 1 1 1 1
Mean Rec. 1.90 1.73 1.73 1.68
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: -90.65
Price Earnings Comparisons:
DXCM Sector Avg. S&P 500
-90.65 0.00 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
11.14% 5.80% 222.44%
Revenue 55.10 3.00 0.58
Net Income 0.00 0.10 0.00
EPS 0.00 -0.10 0.00
Earnings for DXCM:
Revenue 0.40B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $-0.14 $0.03 $-0.58 $0.24
Number of Analysts 13 12 12 12
High Estimate $-0.07 $0.09 $-0.49 $0.60
Low Estimate $-0.20 $-0.03 $-0.65 $-0.15
Prior Year $-0.07 $0.02 $-0.26 $-0.58
Growth Rate (Year over Year) -97.80% 54.17% -121.47% 142.26%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Results on conference picks are split as hedge fund industry contends with criticism.
David Einhorn, Jim Chanos presentations close out 2106's Sohn Investment Conference.
A combination of price and range compression often precedes volatility squeeze breakouts.
Oct 15, 2015 | 7:20 AM EDT
DXCM was upgraded to Outperform, Leerink Partners said. $100 price target. Stock is down sharply, but fundamentals are as strong as eve...

Apple Stock Is Still Cheap Real Money Pro($)

Even at a record valuation, the shares seem poised to move higher.
Jan 06, 2015 | 7:15 AM EST
DXCM was downgraded from Buy to Neutral, Sterne Agee said. Valuation call, as the stock surpassed the previous $56 price target. 
You should be watching how DexCom is trading.
Apr 10, 2014 | 8:04 AM EDT
DXCM was upgraded from Neutral to Buy, Sterne Agee said. $50 price target. Superior CGM technology will continue to drive strong revenu...
Feb 21, 2014 | 8:18 AM EST
DXCM bumped up its number, Jefferies said. Pediatrics and integrated CGM/pump and next gen products supporting growth. $50 price target...

Columnist Conversations

The integrity of the channel parameters on the General Electric GE chart could be a tell as to the short-to-in...
In mid August we added some Dec QCOM calls on a rollup, we take these off now. SOLD QCOM DEC 62.5 CALL AT 6...
Seeing a similar early start to trading as of yesterday.  Open pretty flat follow by reversal, especially...
Not pretty, but former net/net (and current double-net) up 15% yesterday on 2 1/2 times normal average volume ...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.